Granted Patent B2

US 12,280,179 · App. 18/431,234 · Granted Apr 22, 2025

Inventors: Lixiao Wang (Henderson, NV); Peter Barnett (Shakopee, MN); David Hendrickson (Coon Rapids, MN)

Assignee: Urotronic, Inc.

A61L29/08A61L29/06A61L29/085A61L29/16A61M25/1002A61M25/10185A61M29/02A61B1/307A61L2300/416A61L2300/426A61M2025/105A61M2025/1075A61M2202/0488A61M2205/0205A61M2210/0681A61M2210/1032A61M2210/1039A61M2210/105A61M2210/1053A61M2210/1057A61M2210/106A61M2210/1064A61M2210/1078A61M2210/1085A61M2210/1096A61M2210/166

Abstract

Claims (28)

1. A method for treatment of an anastomotic stricture, the method comprising:

providing a balloon catheter such that the balloon catheter is positioned at a target site in a body lumen comprising the anastomotic stricture, the balloon catheter comprising an elongated balloon and a coating layer overlying an exterior surface of the balloon, wherein the coating layer comprises an initial drug load of a therapeutic agent, and wherein the coating layer is flushed or soaked in a solution comprising water or saline;

inflating the balloon at the target site to contact the coating layer with walls of the body lumen at the location of the anastomotic stricture until the balloon achieves an inflated balloon diameter for an inflation period;

deflating the balloon after the inflation period; and

withdrawing the balloon catheter from the body lumen.

2. The method of claim 1 , wherein the coating layer is flushed or soaked prior to positioning the balloon catheter in the body lumen stricture.

3. The method of claim 1 , wherein the coating layer is flushed or soaked after positioning the balloon catheter in the body lumen stricture.

4. The method of claim 1 , wherein the anastomotic stricture is a non-vascular stricture.

5. The method of claim 1 , wherein the balloon has thereon a residual drug amount after the withdrawing, wherein the residual drug amount is 70% or less of the initial drug load.

6. The method of claim 1 , wherein the coating layer is flushed or soaked for a predetermined time period.

7. The method of claim 6 , wherein the predetermined time period in combination with the contacting of the coating layer with the stricture is sufficient to release 37% to 97% of the initial drug load.

8. The method of claim 6 , wherein the predetermined time period comprises at least 1 minute.

9. The method of claim 1 , wherein the elongated balloon has a main diameter, the elongated balloon comprising at least one neck section, the balloon comprising a first main section and a second main section on opposite sides of the neck section.

10. The method of claim 9 , wherein the at least one neck section comprises an inflated diameter that is smaller than the main diameter when the balloon is inflated, during the inflating the inflated diameter of the neck section is the smallest diameter of the balloon catheter between the first main section and the second main section, during the inflating the inflated diameter of the neck section is greater than a diameter of the neck section prior to the inflation, and the at least one neck section comprises an area of reduced compliance during inflation relative to the first main section and the second main section.

11. The method of claim 9 , wherein the drug coating is on the first main section and the neck.

12. The method of claim 9 , wherein the at least one neck section comprises a reinforcing material around a circumference of the neck section to reduce compliance of the neck section during the inflation.

13. The method of claim 1 , wherein inserting the balloon catheter into the target site in the body lumen comprises inserting the balloon catheter and a scope into the target site in the body lumen.

14. The method of claim 13 , wherein the balloon catheter and the scope are positioned side-by-side or the balloon catheter is loaded into the scope.

15. The method of claim 13 , wherein the balloon catheter and the scope are positioned side-by-side.

16. The method of claim 13 , wherein the balloon catheter is loaded into the scope.

17. The method of claim 13 , further comprising visualizing the balloon catheter with the scope before and/or during the inflating.

18. The method of claim 13 , wherein the scope comprises an endoscope, enteroscope, colonoscope, sigmoidoscope, rectoscope, anoscope, rhinoscope, bronchoscope, or a cystoscope.

19. The method of claim 1 , wherein the therapeutic agent is chosen from paclitaxel, docetaxel, taxol, rapamycin, sirolimus, zotarolimus, everolimus, tacrolimus, mTOR inhibitors, analogues thereof, and combinations thereof.

20. A method for treatment of an anastomotic stricture, the method comprising:

providing a balloon catheter such that the balloon catheter is positioned at a target site in a body lumen comprising the anastomotic stricture, the balloon catheter comprising an elongated balloon and a coating layer overlying an exterior surface of the balloon, wherein the coating layer comprises an initial drug load of a therapeutic agent, and wherein the coating layer is soaked in a solution comprising water or saline;

inflating the balloon at the target site to contact the coating layer with walls of the body lumen at the location of the anastomotic stricture until the balloon achieves an inflated balloon diameter for an inflation period;

deflating the balloon after the inflation period; and

withdrawing the balloon catheter from the body lumen.

Assignments (1)

Continuity (14)

References Cited (400)